The Beauty Health Company (SKIN) is a Household & Personal Products company in the Consumer Defensive sector, currently trading at $0.99. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SKIN = $251.57 (+25316.2% from the current price, the stock appears undervalued). Analyst consensus target is SKIN = $2 (+61.6% upside).
Valuation: SKIN trades at a trailing Price-to-Earnings (P/E) of -12.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.39.
Financials: revenue is $301M, -5.7%/yr average growth. Net income is $10M (loss), growing at -62.7%/yr. Net profit margin is -3.2% (negative). Gross margin is 65.3% (-3.1 pp trend).
Balance sheet: total debt is $379M against $61M equity (Debt-to-Equity (D/E) ratio 6.2, leveraged). Current ratio is 1.66 (strong liquidity). Debt-to-assets is 75.8%. Total assets: $500M.
Analyst outlook: 3 / 13 analysts rate SKIN as buy (23%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 25/100 (Fail), Health 33/100 (Fail), Moat 49/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
